Cerebral palsy (CP) is the most prevalent chronic childhood motor disability with an estimated lifetime cost of nearly $1 million per individual. There is evidence that magnesium sulfate (MgSO4) can reduce the incidence of CP for very early preterm infants. Many thousands of pregnant women and their fetuses are exposed to MgSO4 every year in the United States for a variety of indications, and most obstetricians are comfortable with its use.
Disscusion boards licensed and powered by ZoneX v3.3.1 Development supported by LifeForm Inc.
All Rights Reserved by SteadyHealth.com
© 2004 - 2009
This site complies with the HONcode standard for trustworthy health information:
verify here.
